In this study, we cocultured CD44+Fbs or CD44−Fbs and breast cancer cells and found that CD44+Fbs could promote breast cancer cell proliferation and suppress cell apoptosis induced by paclitaxel. Here, CD44 is linked to breast carcinoma.